Intelligent Bio Solutions Inc.

NASDAQ (USD): Intelligent Bio Solutions Inc. (INBS)

Last Price

1.94

Today's Change

+0.10 (5.43%)

Day's Change

1.85 - 1.98

Trading Volume

245,348

Profile
INBS

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Harry Simeonidis Mr. Harry Simeonidis

Full Time Employees:  50 50

IPO Date:  2020-12-23 2020-12-23

CIK:  0001725430 0001725430

ISIN:  US36151G6008 US36151G6008

CUSIP: 

Beta:  4.72 4.72

Last Dividend:  0.00 0.00

Dcf Diff:  3.91 3.91

Dcf:  -1.43 -1.43

Description

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Address

142 West 57th Street,
New York, NY 10019, US

646 828 8258

http://gbs.inc

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment